Cimlanod Completed Phase 1 Trials for hepatic dysfunction / Hepatic Failure / Cardiac Failure / Liver Insufficiency / Decompensation, Heart / Congestive Heart Failure (CHF) / Myocardial Failure Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03515980An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function